Evaluating adverse events of pegvaliase-pqpz in phenylketonuria treatment: A comprehensive safety assessment
Our study provides a deeper insight into the safety profile of pegvaliase-pqpz, thereby aiding healthcare professionals in clinical surveillance and risk identification.
Authors
- Lixuan Yan
- Li Wu (ORCID: https://orcid.org/0000-0002-8469-514X)
- Guang Yang (ORCID: https://orcid.org/0000-0001-7236-7483)
- Li Zhang (ORCID: https://orcid.org/0000-0002-3617-2627)
- HE Pei-feng
- Kai Yan (ORCID: https://orcid.org/0009-0005-4203-4262)
- Qi Yu (ORCID: https://orcid.org/0000-0001-9538-4278)
Institutions
- Shanxi Medical University (CN)
- Second Hospital of Shanxi Medical University (CN)
Publication Details
- Journal
- SAGE Open Medicine
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1177/20503121251330187
- Citations
- 3
- Primary Topic
- Metabolism and Genetic Disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.96